12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Allarity Therapeutics (NASDAQ:ALLR) shares rose 44.0% to $0.86 during Tuesday’s pre-market session. The company’s market cap stands…
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell
• CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Earnings Outlook For Precision BioSciences
Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Tuesday, 2023-11-07. Here’s what investors…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Cellectis (NASDAQ:CLLS) shares moved upwards by 188.6% to $2.8 during Wednesday’s regular session. Trading volume for this…
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
Gainers
Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.
What 4 Analyst Ratings Have To Say About Precision BioSciences
Over the past 3 months, 4 analysts have published their opinion on Precision BioSciences (NASDAQ:DTIL) stock. These analysts…
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 225 companies set new 52-week lows.
What Is Precision BioSciences CAR T Pipeline Value? Analyst Lowers Price Target To Justify Valuation
Wednesday, Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead allogeneic CAR T candidate for cancer.
The Latest Analyst Ratings for Precision BioSciences
Over the past 3 months, 4 analysts have published their opinion on Precision BioSciences (NASDAQ:DTIL) stock. These analysts…